Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Adachi

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
BMC Cancer|September 9, 2022
Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation statusTetsuya Isaka, Hiroyuki Ito, Tomoyuki Yokose, et al.
The Annals of Thoracic Surgery|February 4, 2023
Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung AdenocarcinomaAtsushi Kamigaichi, Takahiro Mimae, Norifumi Tsubokawa, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|August 17, 2023
Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancerAtsushi Kamigaichi, Takahiro Mimae, Norifumi Tsubokawa, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|February 21, 2023
Wedge resection is an acceptable treatment option for radiologically low-grade lung cancer with solid predominanceAtsushi Kamigaichi, Takahiro Mimae, Norifumi Tsubokawa, et al.
Oncogene|March 3, 2004
Niban gene is commonly expressed in the renal tumors: a new candidate marker for renal carcinogenesisHiroyuki Adachi, Shuichi Majima, Shigeyuki Kon, et al.
Journal of Clinical Medicine|February 24, 2024
Suitable Patient Selection and Optimal Timing of Treatment for Persistent Air Leak after Lung ResectionYoshikane Yamauchi, Hiroyuki Adachi, Nobumasa Takahashi, et al.
Journal of Thoracic Disease|August 30, 2019
Retrospective study of efficacy of adjuvant chemotherapy using tegafur-uracil in patients with non-small cell lung cancer with primary tumor size of 4.1-5.0 cmHiroyuki Adachi, Teppei Nishii, Taketsugu Yamamoto, et al.
Translational Lung Cancer Research|November 7, 2024
The time-to-surgery interval and its effect on pathological response after neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a retrospective cohort studyShuai-Dong Lin, Chang-Yong Tong, Dan-Dong Huang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 14, 2021
Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II-IIIA (8th edition TNM classification) primary lung cancer after curative surgeryTetsuya Isaka, Hiroyuki Ito, Haruhiko Nakayama, et al.
Annals of Translational Medicine|September 29, 2022
Association between <i>EGFR</i> gene mutant protein expression and T790M mutation after first-generation EGFR-TKI treatment resistance: a retrospective, single-arm clinical studyYiruo Zhang, Xin Huang, Ruiqi Niu, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
BMC Cancer|September 9, 2022
Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation statusTetsuya Isaka, Hiroyuki Ito, Tomoyuki Yokose, et al.
The Annals of Thoracic Surgery|February 4, 2023
Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung AdenocarcinomaAtsushi Kamigaichi, Takahiro Mimae, Norifumi Tsubokawa, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|August 17, 2023
Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancerAtsushi Kamigaichi, Takahiro Mimae, Norifumi Tsubokawa, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|February 21, 2023
Wedge resection is an acceptable treatment option for radiologically low-grade lung cancer with solid predominanceAtsushi Kamigaichi, Takahiro Mimae, Norifumi Tsubokawa, et al.
Oncogene|March 3, 2004
Niban gene is commonly expressed in the renal tumors: a new candidate marker for renal carcinogenesisHiroyuki Adachi, Shuichi Majima, Shigeyuki Kon, et al.
Journal of Clinical Medicine|February 24, 2024
Suitable Patient Selection and Optimal Timing of Treatment for Persistent Air Leak after Lung ResectionYoshikane Yamauchi, Hiroyuki Adachi, Nobumasa Takahashi, et al.
Journal of Thoracic Disease|August 30, 2019
Retrospective study of efficacy of adjuvant chemotherapy using tegafur-uracil in patients with non-small cell lung cancer with primary tumor size of 4.1-5.0 cmHiroyuki Adachi, Teppei Nishii, Taketsugu Yamamoto, et al.
Translational Lung Cancer Research|November 7, 2024
The time-to-surgery interval and its effect on pathological response after neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a retrospective cohort studyShuai-Dong Lin, Chang-Yong Tong, Dan-Dong Huang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 14, 2021
Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II-IIIA (8th edition TNM classification) primary lung cancer after curative surgeryTetsuya Isaka, Hiroyuki Ito, Haruhiko Nakayama, et al.
Annals of Translational Medicine|September 29, 2022
Association between <i>EGFR</i> gene mutant protein expression and T790M mutation after first-generation EGFR-TKI treatment resistance: a retrospective, single-arm clinical studyYiruo Zhang, Xin Huang, Ruiqi Niu, et al.
Pageof 10